Metraipolis › archive › dc_7fa93af48098

Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis — Europe PMC PMID:31513587

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31513587
DOI
10.1371/journal.pntd.0007687
License (as archived)
CC0-1.0
Archived
2026-11-10T14:56:54.472Z
SHA-256 of the archived text
03d8d7fa73115043dfc535ef25164b285d2c87e476232cf04fe462d762b56601
Stable URL of this page
https://metraipolis.com/documento/dc_7fa93af48098

How to cite

Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis — Europe PMC PMID:31513587 — Europe PMC (en), https://europepmc.org/article/MED/31513587 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7fa93af48098 (Metraipolis archive dc_7fa93af48098, sha256 03d8d7fa73115043dfc535ef25164b285d2c87e476232cf04fe462d762b56601)
BibTeX
@misc{dc7fa93af48098,
  title = {Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis — Europe PMC PMID:31513587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31513587},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7fa93af48098; sha256 03d8d7fa73115043dfc535ef25164b285d2c87e476232cf04fe462d762b56601},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31513587. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Lymphatic filariasis (LF), a morbid disease caused by the tissue-invasive nematodes Wuchereria bancrofti, Brugia malayi, and Brugia timori, affects millions of people worldwide. Global eradication efforts have significantly reduced worldwide prevalence, but complete elimination has been hampered by limitations of current anti-filarial drugs and the lack of a vaccine. The goal of this study was to evaluate B. malayi intestinal UDP-glucuronosyltransferase (Bm-UGT) as a potential therapeutic target. To evaluate whether Bm-UGT is essential for adult filarial worms, we inhibited its expression using siRNA. This resulted in a 75% knockdown of Bm-ugt mRNA for 6 days and almost complete suppression of detectable Bm-UGT by immunoblot. Reduction in Bm-UGT expression resulted in decreased worm motility for 6 days, 70% reduction in microfilaria release from adult worms, and significant reduction in adult worm metabolism as detected by MTT assays. Because prior allergic-sensitization to a filarial antigen would be a contraindication for its use as a vaccine candidate, we tested plasma from infected and endemic normal populations for Bm-UGT-specific IgE using a luciferase immunoprecipitation assay. All samples (n = 35) tested negative. We then tested two commercially available medicines known to be broad inhibitors of UGTs, sulfinpyrazone and probenecid, for in vitro activity against B. malayi. There were marked macrofilaricidal effects at concentrations achievable in humans and very little effect on microfilariae. In addition, we observed that probenecid and sulfinpyrazone exhibit a synergistic macrofilaricidal effect when used in combination with albendazole. The results of this study demonstrate that Bm-UGT is an essential protein for adult worm survival. Lack of prior IgE sensitization in infected and endemic populations suggest it may be a feasible vaccine candidate. The finding that sulfinpyrazone and probenecid have in vitro effects against adult B. malayi worms suggests that these medications have promise as potential macrofilaricides in humans.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2019 (prima pubblicazione 2019-09-12).
Identificativi: PMID 31513587 · PMCID PMC6742224 · DOI 10.1371/journal.pntd.0007687.
Pagina: https://europepmc.org/article/MED/31513587 — https://doi.org/10.1371/journal.pntd.0007687. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-10T14:43:44.275Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.